Use of Dexmedetomidine in pediatric sedation: A literature review
DOI:
https://doi.org/10.33448/rsd-v14i11.49999Keywords:
Dexmedetomidine, Sedation, Adverse effects.Abstract
This study aims to systematically analyze the available evidence in the literature regarding the efficacy, safety, and clinical applicability of dexmedetomidine in pediatric patients, considering its main pharmacological, hemodynamic, and neuroprotective outcomes, with emphasis on differences between administration routes and the practical implications for modern anesthesiology. Dexmedetomidine (DEX) is a highly selective alpha-2 adrenergic agonist that has gained prominence in pediatric sedation due to its sedative, analgesic, and anxiolytic properties, with minimal respiratory depression and a stable hemodynamic profile. An integrative literature review was conducted in the PubMed, SciELO, and LILACS databases, using descriptors in Portuguese, English, and Spanish, to evaluate the available evidence on the efficacy, safety, and clinical applicability of DEX in pediatric patients. Full-text articles published between 2021 and 2025 addressing the use of DEX for pediatric sedation were included, resulting in 20 selected studies out of an initial 177. The results indicate that DEX significantly reduces agitation and postoperative delirium and presents cardioprotective and neuroprotective effects. The intranasal route proved safe and well tolerated, with a low incidence of adverse events, while the intravenous route requires caution due to the possibility of transient bradycardia and hypotension. It is concluded that dexmedetomidine represents a promising and safe option for sedation and analgesia in pediatrics, with the potential to reduce opioid use and recovery time, although further multicenter long-term studies are needed to standardize dosing and infusion protocols and consolidate its routine use.
References
Aislinn O'Kane, Quinney, S. K., Kinney, E., Bergstrom, R. F., & Tillman, E. M. (2024). A systematic review of dexmedetomidine pharmacology in pediatric patients. Clinical and Translational Science, 17(12). https://doi.org/10.1111/cts.70020
Amorim, M. A. S., Govêia, C. S., Magalhães, E., Ladeira, L. C. A., Moreira, L. G., & Miranda, D. B. de. (2017). Effect of dexmedetomidine in children undergoing general anesthesia with sevoflurane: a meta-analysis. Brazilian Journal of Anesthesiology (English Edition), 67(2), 193–198. https://doi.org/10.1016/j.bjane.2016.02.007
Angelopoulou, V.-A., Pouliakis, A., Alexiou, N., Ioannidi, P., Vagiona, D., Ekmektzoglou, K., Xanthos, T., Boutsikou, T., Iliodromiti, Z., & Iacovidou, N. (2023). The Effects of Dexmedetomidine on Children Undergoing Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis. Children (Basel, Switzerland), 10(6), 948. https://doi.org/10.3390/children10060948
Arun, N., Choudhary, A., & Kumar, M. (2022). Comparative Study of Intranasal Dexmedetomidine Versus Intranasal Ketamine as Premedicant in Children. Cureus. https://doi.org/10.7759/cureus.26572
Cater, D. T., Rogerson, C. M., Hobson, M. J., Ackerman, L. L., & Rowan, C. M. (2022). The association of postoperative dexmedetomidine with pain, opiate utilization, and hospital length of stay in children post–Chiari malformation decompression. Journal of Neurosurgery: Pediatrics, 29(3), 312–318. https://doi.org/10.3171/2021.10.peds21291
Dai, C., Zhao, X., Li, A., Zhang, X., Wang, P., Zhang, Y., & Wu, Y. (2025). Comparative evaluation of intravenous versus intranasal dexmedetomidine on emergence delirium and hemodynamics in pediatric patients undergoing adenotonsillectomy: a randomized controlled trial. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.154334
Gozdem Kayki, Yalcin, N., Celik, H. T., & Sule Yigit. (2025). Dexmedetomidine in neonates: utilisation trends and safety profile over time in a neonatal intensive care unit. BMJ Paediatrics Open, 9(1), e003004–e003004. https://doi.org/10.1136/bmjpo-2024-003004
Hu, W., Hu, W., & Hu, W. (2024). Effects of different doses of intranasal dexmedetomidine on related complications and parents’ satisfaction in anesthetized children: a systematic review. BMC Pediatrics, 24(1). https://doi.org/10.1186/s12887-024-04832-w
Jia, Y., Zhou, R., Li, Z., Wang, Y., & Qi, J. (2022). Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.908212
Kesumarini, D., Yunita Widyastuti, Cindy Elfira Boom, & Lucia Kris Dinarti. (2023). Dexmedetomidine as a myocardial protector in pediatric heart surgery using cardiopulmonary bypass: a systematic review. Annals of Medicine and Surgery, 85(10), 5075–5084. https://doi.org/10.1097/ms9.0000000000001170
Lim, J. Y., Ker, C. J., Lai, N. M., Romantsik, O., Fiander, M., & Tan, K. (2024). Dexmedetomidine for analgesia and sedation in newborn infants receiving mechanical ventilation. Cochrane Database of Systematic Reviews, 2024(5). https://doi.org/10.1002/14651858.cd012361.pub2
Lu, X., Tang, L., Lan, H., Li, C., & Lin, H. (2022). A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.808930
Lyu, X., Tao, Y., & Dang, X. (2022). Efficacy and Safety of Intranasal Dexmedetomidine vs. Oral Chloral Hydrate for Sedation in Children Undergoing Computed Tomography/Magnetic Resonance Imaging: A Meta-Analysis. Frontiers in Pediatrics, 10. https://doi.org/10.3389/fped.2022.872900
Marra, P., Arianna Di Stadio, Colacurcio, V., Scarpa, A., Ignazio La Mantia, Francesco Antonio Salzano, & Pietro De Luca. (2022). Sedation with Intranasal Dexmedetomidine in the Pediatric Population for Auditory Brainstem Response Testing: Review of the Existing Literature. Healthcare, 10(2), 287–287. https://doi.org/10.3390/healthcare10020287
Nong, X., Lu, Y., Jiang, W., Qin, Y., Jing, S., Chi, T., Peng, W., Liu, S., & Lin, Y. (2024). Age-related characteristics of sedation in pediatric patients and their correlated adverse events: a cohort study. Frontiers in Pediatrics, 12. https://doi.org/10.3389/fped.2024.1475891
Omid Azimaraghi, Rudolph, M. I., Luedeke, C. M., Ramishvili, T., Jaconia, G. D., Scheffenbichler, F. T., Chambers, T.-A., Karaye, I. M., Eikermann, M., Chao, J., & Jackson, W. M. (2024). Association of dexmedetomidine use with haemodynamics, postoperative recovery, and cost in paediatric anaesthesia: a hospital registry study. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2024.03.016
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [free ebook]. Santa Maria. Editora da UFSM.
Scheckenbach, V., & Fideler, F. (2024). Optimizing Pediatric Sedation: Evaluating Remimazolam and Dexmedetomidine for Safety and Efficacy in Clinical Practice. Pediatric Drugs. https://doi.org/10.1007/s40272-024-00659-1
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of Business Research. 104, 333-9. Doi: https://doi.org/10.1016/j.jbusres.2019.07.039.
Song, J., Liu, S., Fan, B., Li, G., & Sun, Q. (2021). Perioperative dexmedetomidine reduces emergence agitation without increasing the oculocardiac reflex in children. Medicine, 100(18), e25717. https://doi.org/10.1097/md.0000000000025717
Tavares De Souza, M., Dias Da Silva, M., & De Carvalho, R. (2010). Revisão integrativa: o que é e como fazer Integrative review: what is it? How to do it? Einstein, 8(1), 102–108. https://www.scielo.br/j/eins/a/ZQTBkVJZqcWrTT34cXLjtBx/?format=pdf&lang=pt
Wang, Q., Chen, C., & Wang, L. (2022). Efficacy and safety of dexmedetomidine in maintaining hemodynamic stability in pediatric cardiac surgery: a systematic review and meta-analysis. Jornal de Pediatria (English Edition), 98(1), 15–25. https://doi.org/10.1016/j.jped.2021.05.008
Zhang, G., Xin, L., & Yin, Q. (2023). Intranasal dexmedetomidine vs. oral midazolam for premedication in children: a systematic review and meta-analysis. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1264081
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ana Julia Colombo Lyrio, Philiphe Ferrari Naak
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
